From Tumour to Bloodstream: Advancing PD ‐ L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer
Cytopathology · 2026-09 · 37 (5) · 438-448
DOI: 10.1111/cyt.70094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cytopathology, online erschienen am 30.05.2026. Verfasst von R Leporati und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have revolutionised the treatment landscape of non‐small cell lung cancer (NSCLC) without actionable genomic alterations by opening new possibilities for treatment. However, the predictive value of Programmed Death‐Ligand 1 (PD‐L1) expression assessed by immunohistochemistry (IHC) is quite modest, leaving many patients without optimal benefit from ICIs. To address this gap, liquid biopsy is gaining momentum as a promising tool to complement tissue‐based PD‐L1 assessment. Liquid biopsy, which entails the analysis of circulating tumour cells (CTCs), extracellular vesicles (EVs), circulating tumour DNA (ctDNA), and other biomarkers, offers a non‐invasive approach for tracking disease evolution and interactions with the immune system. We conducted a narrative review to explore the potential of liquid biopsy in enhancing patient selection for ICIs, its predictive and prognostic value in advanced NSCLC, and the associated technical and clinical implications. By highlighting recent advancements and ongoing research efforts, we underscore the critical role of liquid biopsy in driving precision immuno‐oncology. Establishing robust, reproducible methods for PD‐L1 assessment through liquid biopsy is essential for translating this approach into clinical practice, with the potential to overcome the limitations of tissue‐based assays and better individualise immunotherapy strategies in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
- Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
- Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Modena, Italy.
- Department of Diagnostic Medicine and Public Health, University of Modena and Reggio Emilia - Section of Pathology, Modena, Italy.
- Molecular Pathology and Predictive Medicine, University Hospital of Modena, Modena, Italy.
ORCID-Profile: R Leporati, V Catani
Zitieren
APA
Leporati, R., Callegari, V., Ancora, A., Palmieri, M., Riccò, B., Cabitza, E., Trudu, L., Di Emidio, K., Chiavelli, C., Eccher, A., Mastrolia, I., Catani, V., Bettelli, S., Guaitoli, G., Dominici, M., & Bertolini, F. (2026). From Tumour to Bloodstream: Advancing PD ‐ L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer. Cytopathology, 37(5), 438-448. https://doi.org/10.1111/cyt.70094
Vancouver
Leporati R, Callegari V, Ancora A, Palmieri M, Riccò B, Cabitza E, et al. From Tumour to Bloodstream: Advancing PD ‐ L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer. Cytopathology. 2026;37(5):438-448. doi:10.1111/cyt.70094
BibTeX
@article{Leporati2026,
author = {Leporati, R and Callegari, V and Ancora, A and Palmieri, M and Riccò, B and Cabitza, E and Trudu, L and Di Emidio, K and Chiavelli, C and Eccher, A and Mastrolia, I and Catani, V and Bettelli, S and Guaitoli, G and Dominici, M and Bertolini, F},
title = {From Tumour to Bloodstream: Advancing PD ‐ L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer},
journal = {Cytopathology},
year = {2026},
volume = {37},
number = {5},
pages = {438--448},
doi = {10.1111/cyt.70094}
}
EUVIMED